{
  "drug_name": "Ceftriaxone",
  "url": "https://wikem.org/wiki/Ceftriaxone",
  "scraped_at": "2026-01-10T03:07:30.428114",
  "sections": {
    "General": {
      "text": "Type: 3rd generation\nCephalosporin\nDosage Forms: injectable solution, powder for injection\nDosage Strengths: injectable solution: 1g/50mL, 2g/50mL; powder for injection: 250mg, 500mg, 1g, 2g, 10g, 100g\nRoutes of Administration: IV, IM\nCommon Trade Names: Rocephin",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Cephalosporin",
          "url": "https://wikem.org/wiki/Cephalosporin"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "General_2": {
          "text": "1-2g IM/IV q24h\nFirst ED Dose: 1g IM/IV x 1\nMax: 4g/24h",
          "tables": []
        },
        "Bacterial_Meningitis": {
          "text": "4g IV divided q12-24h x 7-21 days\nFirst ED Dose: 2g IM/IV x 1",
          "tables": []
        },
        "Gonococcal": {
          "text": "Uncomplicated, initial: 250mg IM x 1\nAlso treat for chlamydia regardless of test results\nUncomplicated, recurrent of persistent: 500-1000mg IM x 1\nDisseminated: 1g IM/IV q24h\nMay switch to cefixime PO after 24-48h if clinical improvement\nConjunctivitis: 1g IM x 1\nProphylaxis (sexual assault victims)\n250mg IM x 1",
          "tables": []
        },
        "PID": {
          "text": "250mg IM x 1\nUse with doxycycline +/- metronidazole",
          "tables": []
        },
        "Sinusitis,_Severe": {
          "text": "1-2g IV q12-24h x 7-10 days",
          "tables": []
        },
        "Endocarditis": {
          "text": "1g IM/IV x 1\n30-60 min before procedure",
          "tables": []
        },
        "Proctitis,_Epididymitis,_Chancroid": {
          "text": "250mg IM x 1\nGive with doxycycline",
          "tables": []
        },
        "Surgical_Prophylaxis": {
          "text": "1g IV x 1\nGive 0.5-2h preop",
          "tables": []
        },
        "Typhoid_Fever": {
          "text": "60mg/kg IV q24h x 2wk\nMax: 4g/24h",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "",
      "subsections": {
        "General_(<7_Days_Old)": {
          "text": "50mg/kg IM/IV q24h\nFirst Dose: 50mg/kg IM/IV x 1",
          "tables": []
        },
        "General_(7_Days_-_1_Month)": {
          "text": "<2000g\n50mg/kg IM/IV q24h\nFirst Dose: 50mg/kg IM/IV x 1\n>2000g\n50-75mg/kg IM/IV q24h\nFirst Dose: 50-75mg/kg IM/IV x 1",
          "tables": []
        },
        "General_(>1_Month_-_Adult)": {
          "text": "50-100mg/kg IM/IV divided q12-24h\nFirst Dose: 50-100mg/kg IM/IV x 1\nMax: 4g/24h",
          "tables": []
        },
        "Acute_Otitis_Media_(2_Months_-_12_Years)": {
          "text": "50mg/kg IM/IV x 1\nGive 50mg/kg IM/IV q24h x 3 days for recurrent infection\nMax 1g/dose",
          "tables": []
        },
        "Bacterial_Meningitis_2": {
          "text": "80-100mg/kg IV divided q12-24h x 7-21 days\nFirst Dose: 100mg/kg IV x 1\nMax: 4g/24h",
          "tables": []
        },
        "Pneumonia,_Community-Acquired_(>3_Months)": {
          "text": "50-100mg/kg/day IM/IV divided q12-24h x 10 days\nFirst Dose:\nMax: 2g/day\nInfo: May switch to PO when possible to complete course",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: B\nLactation: Probably safe\nRenal Dosing\nAdult\nRenal failure: No initial adjustment, monitor serum levels\nHemodialysis: give dose after dialysis, no supplement\nPeritoneal Dialysis: 750mg q12h\nPediatric\nCrCl <10: give q24h\nHemodialysis: 50mg/kg q24, no supplement\nPeritoneal Dialysis: 50mg/kg q24, no supplement\nHepatic Dosing\nAdult\nHepatic and renal disease: max 2g/day, unless closely monitoring serum levels\nPediatric\nMay requrire dose adjustment but specific dosing not defined",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_Ratings_in_Pregnancy"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug (see also\nCephalosporin Cross-reactivity\n)\nPatients <1 month old\nHyperbillirubinemia\nIV calcium containing product\nIf a 3rd generation cephalosporin is required, consider using Cefotaxime instead",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Cephalosporin Cross-reactivity",
          "url": "https://wikem.org/wiki/Cephalosporin_Cross-reactivity"
        }
      ]
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Anaphylaxis\nBroncospasm\nStevens-Johnson Syndrome\nToxic Epidermal Necrolysis\nErythema multiforme\nSerum sickness\nPneumonitis\nNeutropenia\nLeukopenia\nHemolytic anemia\nThrombocytopenia\nHypoprothrombinemia\nAgranulocytosis\nSuperinfection\nClostridium difficile\nColitis\nBilliary/gallbladder sludge\nJaundice\nPancreatitis\nSeizures\nNephrolithiasis\nLung/kidney calcium precipitate (neonates)",
          "tables": []
        },
        "Common": {
          "text": "Local infection site reaction\nEosinophilia\nThrombocytosis\nTransaminitis\nDiarrhea\nLeukopenia",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Anaphylaxis",
          "url": "https://wikem.org/wiki/Anaphylaxis"
        },
        {
          "text": "Stevens-Johnson Syndrome",
          "url": "https://wikem.org/wiki/Stevens-Johnson_Syndrome"
        },
        {
          "text": "Toxic Epidermal Necrolysis",
          "url": "https://wikem.org/wiki/Toxic_Epidermal_Necrolysis"
        },
        {
          "text": "Thrombocytopenia",
          "url": "https://wikem.org/wiki/Thrombocytopenia"
        },
        {
          "text": "Clostridium difficile",
          "url": "https://wikem.org/wiki/Clostridium_difficile"
        },
        {
          "text": "Jaundice",
          "url": "https://wikem.org/wiki/Jaundice"
        },
        {
          "text": "Pancreatitis",
          "url": "https://wikem.org/wiki/Pancreatitis"
        },
        {
          "text": "Seizures",
          "url": "https://wikem.org/wiki/Seizures"
        },
        {
          "text": "Nephrolithiasis",
          "url": "https://wikem.org/wiki/Nephrolithiasis"
        },
        {
          "text": "Diarrhea",
          "url": "https://wikem.org/wiki/Diarrhea"
        }
      ]
    },
    "Pharmacology": {
      "text": "Half-life: 5.8-8.7h, 15h (CrCl 5-15)\nMetabolism: CYP450\nExcretion: Primarily urine\nMechanism of Action: bactericidal; inhibits cell wall synthesis",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}